Pharming Group N.V.

PHGUF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$54,944$61,741$207,342$191,725
Short-Term Investments$112,949$151,683$0$0
Receivables$50,172$42,615$25,331$27,591
Inventory$55,724$56,760$42,326$27,282
Other Curr. Assets$4,651$3,543$2,501$2,619
Total Curr. Assets$278,440$316,342$277,500$249,185
Property Plant & Equip (Net)$24,134$33,438$39,145$33,131
Goodwill$0$0$0-$87
Intangibles$61,039$71,267$75,121$83,834
Long-Term Investments$4,233$10,398$9,731$9,949
Tax Assets$41,912$29,761$22,973$21,194
Other NC Assets-$9,773$1,620$1,327-$303
Total NC Assets$121,545$146,512$148,297$147,717
Other Assets$0$0$0$0
Total Assets$399,985$462,854$425,797$396,902
Liabilities
Payables$10,103$9,775$8,174$6,676
Short-Term Debt$7,191$5,440$5,233$4,298
Tax Payable$3,284$6,234$2,099$1,505
Deferred Revenue$0$0-$45,840-$34,857
Other Curr. Liab.$53,204$56,519$44,192$34,292
Total Curr. Liab.$73,782$77,968$59,698$46,721
LT Debt$105,101$165,992$159,488$157,463
Deferred Rev, NC$0$0-$6,256-$5,806
Deferred Tax Liab, NC$11,376$8,095$6,256$5,806
Other NC Liab.$0$0$1,973$2
Total NC Liab.$116,469$174,063$161,461$157,465
Other Liabilities$0$0$0$0
Cap. Leases$29,914$33,123$31,335$20,875
Total Liabilities$178,924$244,073$221,159$204,186
Equity
Pref Stock$0$0$0$0
Common Stock$7,769$6,947$7,509$7,429
Retained Earnings-$275,489-$265,262-$256,431-$273,167
AOCI-$209-$2,057-$8,737$3,400
Other Equity$488,990$478,758$462,297$455,054
Total Equity$221,061$218,781$204,638$192,716
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$411,253$462,854$425,797$396,902
Net Debt$57,348$109,691-$42,621-$29,964